India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market- 2020-2027
India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market is segmented By Medication Type (HCV Protease Inhibitors, HCV Polymerase Inhibitors (Sofosbuvir (Sovaldi)), HCV NS5A Inhibitors, Interferons and ribavirin (Interferon alfa-2b (Intron-A), Peginterferon alfa-2b (PEG-Intron, Sylatron), Pegylated interferon alfa-2a (Pegasys), Ribavirin (Rebetol, Virazole, Copegus, Moderiba, Ribasphere)), Combination Products (Ledipasvir/sofosbuvir (Harvoni), Ombitasvir/paritaprevir/ritonavir & dasabuvir (Viekira Pak), Ombitasvir/paritaprevir/ritonavir (Technivie), Elbasvir/grazoprevir (Zepatier), Glecaprevir/pibrentasvir (Mavyret), Sofosbuvir/velpatasvir (Epclusa), Sofosbuvir/velpatasvir/voxilaprevir (Vosevi)), Thrombopoietin-Receptor Agonists (Eltrombopag (Promacta)), Others), By Disease Type (Acute Hepatitis C, Chronic Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and By Region – Share, Size, Outlook, and Opportunity Analysis, 2020-2027
Market Overview
The India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market is expected to grow at a CAGR during the forecasting period (2020-2027).
Hepatitis C Virus (HCV) is an infection which affects the liver which may lead to serious consequences if not taken care of. It spreads through infected blood transfusions and poorly sterilized medical equipments.
The number of patients has increased significantly because its symptoms take time to be recognized before the patient progresses towards a clinically visible liver damage which worsens the situation since it may lead to liver damage or even failure.
There was no proper therapy for HCV before 2010 but the coming of therapies like Sovaldi and Harvoni by Gilead and Viekira Pak by AbbVie has improved the scenario. Also the steps taken like proper blood screening is also helping in identifying the patients.
Some of the major players include: AbbVie Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc, Merck, F. Hoffmann-La Roche Ltd, among other
Why Purchase the Report?
Visualize the composition of the Hepatitis C Virus (HCV) Treatment market segmentation by form medication type, disease type, and distribution channel highlighting the key commercial assets and players.
Identify commercial opportunities in Hepatitis C Virus (HCV) Treatment market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of Hepatitis C Virus (HCV) Treatment market - level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study. Product mapping in excel for the key product of all major market players
Target Audience:-
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Research Professionals
Emerging Companies
Manufacturers
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market Methodology and Scope
- Research Methodology
- Research Objective and Scope of the Report
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – Market Definition and Overview
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – Executive Summary
- Market Snippet by Medication Type
- Market snippet by Disease Type
- Market Snippet by Distribution Channel
- Market Snippet by Country
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market-Market Dynamics
- Market Impacting Factors
- Drivers
- XX
- XX
- Restraints:
- XX
- XX
- Opportunity
- Impact Analysis
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – Industry Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Pipeline Analysis
- Regulatory Analysis
- Supply Chain Analysis
- Pricing Analysis
- Unmet Needs
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – COVID-19 Analysis
- Analysis of Covid-19 on the Market
- Pricing Dynamics Amid Covid-19
- Demand-Supply Spectrum
- Government Initiatives Related to the Market During Pandemic
- Manufacturers Strategic Initiatives
- Conclusion
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – By Medication Type
- Introduction
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type Segment
- Market Attractiveness Index, By Medication Type Segment
- HCV Protease Inhibitors*
- Introduction
- Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
- HCV Polymerase Inhibitors
- Sofosbuvir (Sovaldi)
- HCV NS5A Inhibitors
- Interferons and ribavirin
- Interferon alfa-2b (Intron-A)
- Peginterferon alfa-2b (PEG-Intron, Sylatron)
- Pegylated interferon alfa-2a (Pegasys)
- Ribavirin (Rebetol, Virazole, Copegus, Moderiba, Ribasphere)
- Combination Products
- Ledipasvir/sofosbuvir (Harvoni)
- Ombitasvir/paritaprevir/ritonavir & dasabuvir (Viekira Pak)
- Ombitasvir/paritaprevir/ritonavir (Technivie)
- Elbasvir/grazoprevir (Zepatier)
- Glecaprevir/pibrentasvir (Mavyret)
- Sofosbuvir/velpatasvir (Epclusa)
- Sofosbuvir/velpatasvir/voxilaprevir (Vosevi)
- Thrombopoietin-Receptor Agonists
- Eltrombopag (Promacta)
- Others
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – By Disease Type
- Introduction
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Attractiveness Index, By Disease Type
- Acute Hepatitis C*
- Introduction
- Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
- Chronic Hepatitis C
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – By Distribution Channel
- Introduction
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
- Market Attractiveness Index, By Distribution Channel Segment
- Hospital Pharmacies* *
- Introduction
- Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
- Retail Pharmacies
- Online Pharmacies
- Others
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – By Country
- Introduction
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
- Market Attractiveness Index, By Country
- India
- Introduction
- Key Region-Specific Dynamics
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- Pakistan
- Introduction
- Key Region-Specific Dynamics
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- Cambodia
- Introduction
- Key Region-Specific Dynamics
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Medication Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type
- Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – Competitive Landscape
- Competitive Scenario
- Market Positioning/Share Analysis
- Mergers and Acquisitions Analysis
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market- Company Profiles
- Merck & Co. Inc.*
- Company Overview
- Product Portfolio and Description
- Key Highlights
- Financial Overview
- GlaxoSmithKline plc
- Gilead Sciences
- Bristol-Myers Squibb Company
- Janssen (Johnson & Johnson)
- AbbVie, Inc.
- F. Hoffmann-La Roche Ltd
- Others (List Not Exhaustive)
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – Premium Insights
- India, Pakistan & Cambodia HEPATITIS C VIRUS (HCV) Treatment Market – DataM
- Appendix
- About Us and Services
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook